BOSTON: Research with seniors over age 50 has determined that persistent depression doubles the risk of stroke for older people and this danger remains high even if the symptoms of depression go away. This is particularly true for women.

Researchers used data from 16,178 participants Read More »

LOS ANGELES: The Hebrew University of Jerusalem received a $0 million gift to launch the second stage of development of the school’s center for brain sciences.

The Edmond J. Safra Philanthropic Foundation donates this multi-million gift five years after they gifted the university $20 million Read More »

PORTLAND: Researchers have been able to characterize for the first time changes in early-stage Alzheimer’s disease that occur inside individual brains.

Results from the study suggest that Alzheimer’s-affected cells result in a reduction of electrical activity throughout the cerebral cortex — the brain’s center of Read More »

TULSA: A newly formed Bermuda-based biotech run by former hedge fund partner Vivek Ramaswamy has struck a deal to in-license a shelved Alzheimer’s drug from GlaxoSmithKline ($GSK) with plans to put it into Phase III.

That late-stage study won’t start until the fourth quarter, but Read More »